Prestige Consumer Healthcare Inc.

NYSE:PBH 주식 보고서

시가총액: US$4.4b

Prestige Consumer Healthcare 미래 성장

Future 기준 확인 1/6

Prestige Consumer Healthcare (는) 각각 연간 4.4% 및 1.9% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 5.1% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 10.4% 로 예상됩니다.

주요 정보

4.4%

수익 성장률

5.13%

EPS 성장률

Pharmaceuticals 수익 성장14.6%
매출 성장률1.9%
향후 자기자본 수익률10.40%
애널리스트 커버리지

Good

마지막 업데이트16 May 2025

최근 미래 성장 업데이트

Results: Prestige Consumer Healthcare Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 09
Results: Prestige Consumer Healthcare Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Recent updates

These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Reasonably Well

May 09
These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Reasonably Well

Prestige Consumer Healthcare Inc. (NYSE:PBH) Investors Are Less Pessimistic Than Expected

Apr 16
Prestige Consumer Healthcare Inc. (NYSE:PBH) Investors Are Less Pessimistic Than Expected

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 70% Above Its Share Price

Mar 05
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 70% Above Its Share Price

Results: Prestige Consumer Healthcare Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 09
Results: Prestige Consumer Healthcare Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Feb 07
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Pinning Down Prestige Consumer Healthcare Inc.'s (NYSE:PBH) P/S Is Difficult Right Now

Jan 16
Pinning Down Prestige Consumer Healthcare Inc.'s (NYSE:PBH) P/S Is Difficult Right Now

Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 45% Below Their Intrinsic Value Estimate

Dec 04
Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 45% Below Their Intrinsic Value Estimate

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Nov 03
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Sep 10
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing
author-image

Brand Building And Innovations Propel Long-Term Growth Amid Supply Chain Challenges

Investments in brand building and marketing for key products like Hydralyte and Summer's Eve are enhancing consumer awareness and driving revenue growth.

Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Jul 16
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Revenues Not Telling The Story For Prestige Consumer Healthcare Inc. (NYSE:PBH)

May 22
Revenues Not Telling The Story For Prestige Consumer Healthcare Inc. (NYSE:PBH)

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 26
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Mar 05
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Feb 11
Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon

Feb 05
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Dec 14
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Sep 10
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Prestige Consumer Healthcare: Unproductive Buyback And Excessive Valuation

Aug 15

Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?

Jun 12
Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued

May 20
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors

Mar 17
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 02
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price

Feb 08
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price

Prestige Consumer Healthcare reports Q3 earnings beat; updates FY23 guidance

Feb 02

Prestige Consumer Healthcare: Taking My Winnings Off The Table

Jan 19

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Nov 23
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare GAAP EPS of $1.02 beats by $0.02, revenue of $289.3M beats by $6.07M

Nov 03

Holding Prestige Consumer Healthcare

Aug 31

If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

Aug 26
If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Aug 05
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Prestige Consumer Healthcare GAAP EPS of $1.09 beats by $0.05, revenue of $277.1M beats by $8.18M

Aug 04

Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

May 27
Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

May 05
Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Feb 22
Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

수익 및 매출 성장 예측

NYSE:PBH - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
3/31/20281,1982532732882
3/31/20271,1762502803057
3/31/20261,1512382762927
3/31/20251,138215243252N/A
12/31/20241,118214249257N/A
9/30/20241,111206255263N/A
6/30/20241,113205246256N/A
3/31/20241,125209239249N/A
12/31/20231,134-81232241N/A
9/30/20231,127-82216224N/A
6/30/20231,130-84211220N/A
3/31/20231,128-82222230N/A
12/31/20221,109210225234N/A
9/30/20221,108209236245N/A
6/30/20221,095203240249N/A
3/31/20221,087205250260N/A
12/31/20211,058189245256N/A
9/30/20211,022179224239N/A
6/30/2021983179209230N/A
3/31/2021943165213236N/A
12/31/2020957166207233N/A
9/30/2020960163218241N/A
6/30/2020960152222240N/A
3/31/2020963142203217N/A
12/31/2019953-34199212N/A
9/30/2019953-34186197N/A
6/30/2019954-36176186N/A
3/31/2019976-36179189N/A
12/31/201899164N/A193N/A
9/30/20181,020340N/A197N/A
6/30/20181,039340N/A212N/A
3/31/20181,041340N/A210N/A
12/31/20171,026390N/A163N/A
9/30/2017972107N/A156N/A
6/30/2017929109N/A151N/A
3/31/201788269N/A149N/A
12/31/201684972N/A179N/A
9/30/201683369N/A185N/A
6/30/201682468N/A182N/A
3/31/2016806100N/A176N/A
12/31/2015788110N/A189N/A
9/30/2015786103N/A190N/A
6/30/201576188N/A170N/A
3/31/201571578N/A156N/A
12/31/201466870N/A135N/A
9/30/201461552N/A113N/A
6/30/201460169N/A118N/A

애널리스트 미래 성장 예측

수입 대 저축률: PBH 의 연간 예상 수익 증가율( 4.4% )이 saving rate( 2.8% 보다 높습니다. ).

수익 vs 시장: PBH 의 연간 수익( 4.4% ) US 시장( 14.3% 보다 느리게 성장할 것으로 예상됩니다. 14.3% 연간).

고성장 수익: PBH 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: PBH 의 수익(연간 1.9% ) US 시장( 8.5% 보다 느리게 성장할 것으로 예상됩니다. 8.5% 연간).

고성장 수익: PBH 의 수익(연간 1.9% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: PBH 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 10.4 %).


성장 기업 발견

기업 분석 및 재무 데이터 현황

데이터마지막 업데이트(UTC 시간)
기업 분석2025/05/19 16:21
장 마감 주가2025/05/19 00:00
수익2025/03/31
연간 수익2025/03/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
회사 재무10년
  • 손익 계산서
  • 현금 흐름표
  • 대차 대조표
애널리스트 컨센서스 추정치+3년
  • 재무 예측
  • 애널리스트 목표가
시장 가격30년
  • 주식 가격
  • 배당금, 분할 및 액션
소유권10년
  • 최대 주주
  • 내부자 거래
관리10년
  • 리더십 팀
  • 이사회
주요 개발 사항10년
  • 회사 공지 사항

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처는 미국 증권의 예를 사용했습니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 Github에서 확인할 수 있습니다.

애널리스트 출처

Prestige Consumer Healthcare Inc. 16 애널리스트 중 7 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가교육기관
Olivia Tong CheangBofA Global Research
Linda Bolton-WeiserB. Riley Securities, Inc.
Susan AndersonCanaccord Genuity